Polyreactive antibodies in adaptive immune responses to viruses
H Mouquet, MC Nussenzweig - Cellular and Molecular Life Sciences, 2012 - Springer
B cells express immunoglobulins on their surface where they serve as antigen receptors.
When secreted as antibodies, the same molecules are key elements of the humoral immune …
When secreted as antibodies, the same molecules are key elements of the humoral immune …
Rheumatic conditions in human immunodeficiency virus infection
UA Walker, A Tyndall, T Daikeler - Rheumatology, 2008 - academic.oup.com
Many rheumatic diseases have been observed in HIV-infected persons. We, therefore,
conducted a comprehensive literature search in order to review the prevalence, presentation …
conducted a comprehensive literature search in order to review the prevalence, presentation …
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines
MA Moody, HX Liao, SM Alam, RM Scearce… - Journal of Experimental …, 2010 - rupress.org
Traditional antibody-mediated neutralization of HIV-1 infection is thought to result from the
binding of antibodies to virions, thus preventing virus entry. However, antibodies that broadly …
binding of antibodies to virions, thus preventing virus entry. However, antibodies that broadly …
Concomitant systemic lupus erythematosus and HIV: case series and literature review
GM Mody, N Patel, A Budhoo, T Dubula - Seminars in Arthritis and …, 2014 - Elsevier
Objectives To determine the effect of systemic lupus erythematosus (SLE) and human
immunodeficiency virus (HIV) infection on the course of each other and to review the …
immunodeficiency virus (HIV) infection on the course of each other and to review the …
9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity
JJ Kobie, DC Alcena, B Zheng, P Bryk, JL Mattiacio… - PloS one, 2012 - journals.plos.org
The induction of a broadly neutralizing antibody (BNAb) response against HIV-1 would be a
desirable feature of a protective vaccine. Vaccine strategies thus far have failed to elicit …
desirable feature of a protective vaccine. Vaccine strategies thus far have failed to elicit …
[HTML][HTML] Infecciones en pacientes con lupus eritematoso sistémico
M Enberg, M Kahn Ch, C Goity, MV Villalón… - Revista médica de …, 2009 - SciELO Chile
Infecciones en pacientes con lupus eritematoso sistémico SciELO - Scientific Electronic
Library Online vol.137 número10 Uso del dispositivo de asistencia respiratoria Novalung® …
Library Online vol.137 número10 Uso del dispositivo de asistencia respiratoria Novalung® …
Concomitant systemic lupus erythematosus and HIV infection: a rare case report and literature review
HY Liao, CM Tao, J Su - Medicine, 2017 - journals.lww.com
Interventions: The treatment plan included methylprednisolone and cyclophosphamide, with
gastroprotective and hepatoprotective agents, simultaneously aiming to reduce urinary …
gastroprotective and hepatoprotective agents, simultaneously aiming to reduce urinary …
Complement and antibodies: a dangerous liaison in HIV infection?
H Stoiber, A Soederholm, D Wilflingseder… - Vaccine, 2008 - Elsevier
Due to ongoing recombination and mutations, HIV permanently escapes from neutralizing
antibody (nAb) responses of the host. By the masking of epitopes or shedding of gp120, HIV …
antibody (nAb) responses of the host. By the masking of epitopes or shedding of gp120, HIV …
Emerging role for complement in HIV infection
G Huber, Z Banki, S Lengauer… - Current Opinion in HIV …, 2011 - journals.lww.com
Emerging role for complement in HIV infection : Current Opinion in HIV and AIDS Emerging
role for complement in HIV infection : Current Opinion in HIV and AIDS Log in or Register …
role for complement in HIV infection : Current Opinion in HIV and AIDS Log in or Register …
Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccine
SA Planque, Y Mitsuda, Y Nishiyama… - The Journal of …, 2012 - journals.aai.org
Failure to induce synthesis of neutralizing Abs to the CD4 binding determinant (CD4BD) of
gp120, a central objective in HIV vaccine research, has been alternately ascribed to …
gp120, a central objective in HIV vaccine research, has been alternately ascribed to …